| RS2126611738 |
TRIO
|
Health Risk |
Likely pathogenic |
Micrognathia-recurrent infections-behavioral abnormalities-mild intellectual disability syndrome, Micrognathia-recurrent infections-behavioral abnormalities-mild intellectual disability syndrome |
| RS2126614292 |
TERT
|
Health Risk |
Pathogenic/Likely pathogenic |
Idiopathic Pulmonary Fibrosis, Dyskeratosis congenita |
| RS2126616654 |
SLC9A3
|
Health Risk |
Likely pathogenic |
— |
| RS2126617138 |
MMAA
|
Health Risk |
Pathogenic |
Methylmalonic aciduria, cblA type |
| RS2126617841 |
TERT
|
Health Risk |
Pathogenic |
Idiopathic Pulmonary Fibrosis, Dyskeratosis congenita |
| RS2126617890 |
TERT
|
Health Risk |
Conflicting classifications of pathogenicity |
Dyskeratosis congenita, autosomal dominant 2 |
| RS2126619895 |
DNAH5
|
Health Risk |
Pathogenic |
Primary ciliary dyskinesia, Primary ciliary dyskinesia |
| RS2126619930 |
MMAA
|
Health Risk |
Pathogenic |
Methylmalonic aciduria, cblA type |
| RS2126619946 |
DNAH5
|
Health Risk |
Pathogenic |
Primary ciliary dyskinesia, Primary ciliary dyskinesia |
| RS2126620903 |
DNAH5
|
Health Risk |
Pathogenic |
Primary ciliary dyskinesia, Primary ciliary dyskinesia |
| RS2126621004 |
DNAH5
|
Health Risk |
Pathogenic |
Primary ciliary dyskinesia, Primary ciliary dyskinesia |
| RS2126621163 |
SLC9A3
|
Health Risk |
Pathogenic |
— |
| RS2126622813 |
MMAA
|
Health Risk |
Pathogenic/Likely pathogenic |
Methylmalonic aciduria, cblA type |
| RS2126627182 |
MMAA
|
Health Risk |
Pathogenic |
Methylmalonic aciduria, cblA type |
| RS2126629821 |
MMAA
|
Health Risk |
Conflicting classifications of pathogenicity |
See cases, Methylmalonic aciduria |
| RS2126631964 |
SDHA
|
Health Risk |
Pathogenic |
Mitochondrial complex II deficiency, nuclear type 1 |
| RS2126632404 |
SDHA
|
Health Risk |
Pathogenic |
Mitochondrial complex II deficiency, nuclear type 1 |
| RS2126633124 |
SDHA
|
Health Risk |
Likely pathogenic |
Mitochondrial complex II deficiency, nuclear type 1 |
| RS2126633433 |
SDHA
|
Health Risk |
Likely pathogenic |
— |
| RS2126633452 |
RETREG1
|
Health Risk |
Pathogenic |
— |
| RS2126633505 |
SDHA
|
Health Risk |
Pathogenic |
Mitochondrial complex II deficiency, nuclear type 1 |
| RS2126633648 |
SDHA
|
Health Risk |
Pathogenic |
Mitochondrial complex II deficiency, nuclear type 1 |
| RS2126637259 |
TRIO
|
Health Risk |
Likely pathogenic |
— |
| RS2126640512 |
ANKH;ANKH-DT
|
Health Risk |
Likely pathogenic |
Chondrocalcinosis 2, Rare epilepsy |
| RS2126641674 |
SDHA
|
Health Risk |
Conflicting classifications of pathogenicity |
Mitochondrial complex II deficiency, nuclear type 1 |
| RS2126644399 |
TERT
|
Health Risk |
Pathogenic |
Idiopathic Pulmonary Fibrosis, Dyskeratosis congenita |
| RS2126645870 |
MTRR
|
Health Risk |
Likely pathogenic |
Neural tube defects, folate-sensitive |
| RS2126647142 |
ADGRV1
|
Health Risk |
Pathogenic |
— |
| RS2126649912 |
TERT
|
Health Risk |
Pathogenic |
Idiopathic Pulmonary Fibrosis, Dyskeratosis congenita |
| RS2126657667 |
NR3C2
|
Health Risk |
Likely pathogenic |
Autosomal dominant pseudohypoaldosteronism type 1, Autosomal dominant pseudohypoaldosteronism type 1 |
| RS2126660137 |
TRIO
|
Health Risk |
Pathogenic |
— |
| RS2126663415 |
MTRR
|
Health Risk |
Pathogenic |
Methylcobalamin deficiency type cblE, Methylcobalamin deficiency type cblE |
| RS2126675629 |
MTRR
|
Health Risk |
Pathogenic |
Methylcobalamin deficiency type cblE, Methylcobalamin deficiency type cblE |
| RS2126675707 |
MTRR
|
Health Risk |
Pathogenic/Likely pathogenic |
Methylcobalamin deficiency type cblE, MTRR-related disorder |
| RS2126676051 |
MTRR
|
Health Risk |
Likely pathogenic |
Methylcobalamin deficiency type cblE, Methylcobalamin deficiency type cblE |
| RS2126684234 |
TERT
|
Health Risk |
Pathogenic |
Dyskeratosis congenita, autosomal dominant 2 |
| RS2126684546 |
HSD17B4
|
Health Risk |
Likely pathogenic |
Bifunctional peroxisomal enzyme deficiency, Bifunctional peroxisomal enzyme deficiency |
| RS2126684848 |
TERT
|
Health Risk |
Pathogenic |
Dyskeratosis congenita, autosomal dominant 2 |
| RS2126685887 |
TERT
|
Health Risk |
Pathogenic |
Idiopathic Pulmonary Fibrosis, Dyskeratosis congenita |
| RS2126686445 |
TERT
|
Health Risk |
Pathogenic |
Idiopathic Pulmonary Fibrosis, Dyskeratosis congenita |
| RS2126687935 |
TERT
|
Health Risk |
Pathogenic |
Dyskeratosis congenita, autosomal dominant 2 |
| RS2126688998 |
TERT
|
Health Risk |
Pathogenic |
Dyskeratosis congenita, Dyskeratosis congenita |
| RS2126689141 |
DNAH5
|
Health Risk |
Likely pathogenic |
Primary ciliary dyskinesia 3, Primary ciliary dyskinesia 3 |
| RS2126689875 |
HSD17B4
|
Health Risk |
Pathogenic/Likely pathogenic |
Perrault syndrome, Bifunctional peroxisomal enzyme deficiency |
| RS2126689896 |
HSD17B4
|
Health Risk |
Pathogenic |
Bifunctional peroxisomal enzyme deficiency, Bifunctional peroxisomal enzyme deficiency |
| RS2126690458 |
HSD17B4
|
Health Risk |
Conflicting classifications of pathogenicity |
Perrault syndrome 1, Bifunctional peroxisomal enzyme deficiency |
| RS2126691326 |
TERT
|
Health Risk |
Likely pathogenic |
Dyskeratosis congenita, autosomal dominant 2 |
| RS2126691416 |
TERT
|
Health Risk |
Pathogenic |
Dyskeratosis congenita, autosomal dominant 2 |
| RS2126692827 |
MTRR
|
Health Risk |
Likely pathogenic |
Methylcobalamin deficiency type cblE, Methylcobalamin deficiency type cblE |
| RS2126693109 |
TERT
|
Health Risk |
Pathogenic |
Dyskeratosis congenita, autosomal dominant 2 |
| RS2126694391 |
DNAH5
|
Health Risk |
Likely pathogenic |
Primary ciliary dyskinesia, Primary ciliary dyskinesia |
| RS2126696915 |
HSD17B4
|
Health Risk |
Pathogenic |
Bifunctional peroxisomal enzyme deficiency, Perrault syndrome |
| RS2126696991 |
HSD17B4
|
Health Risk |
Likely pathogenic |
HSD17B4-related disorder, HSD17B4-related disorder |
| RS2126697261 |
SLC12A2
|
Health Risk |
Likely pathogenic |
See cases, See cases |
| RS2126700213 |
DNAH5
|
Health Risk |
Likely pathogenic |
Primary ciliary dyskinesia, Primary ciliary dyskinesia |
| RS2126702418 |
HSD17B4
|
Health Risk |
Pathogenic |
Perrault syndrome, Bifunctional peroxisomal enzyme deficiency |
| RS2126702600 |
HSD17B4
|
Health Risk |
Likely pathogenic |
Perrault syndrome 1, Perrault syndrome 1 |
| RS2126703106 |
HSD17B4
|
Health Risk |
Pathogenic |
Bifunctional peroxisomal enzyme deficiency, Perrault syndrome |
| RS2126703227 |
HSD17B4
|
Health Risk |
Pathogenic |
Bifunctional peroxisomal enzyme deficiency, Perrault syndrome |
| RS2126727585 |
MTRR
|
Health Risk |
Pathogenic |
Methylcobalamin deficiency type cblE, Methylcobalamin deficiency type cblE |
| RS2126727754 |
DNAH5
|
Health Risk |
Pathogenic |
Primary ciliary dyskinesia, Primary ciliary dyskinesia |
| RS2126728109 |
DNAH5
|
Health Risk |
Pathogenic |
— |
| RS2126731736 |
F11
|
Health Risk |
Likely pathogenic |
Hereditary factor XI deficiency disease, Hereditary factor XI deficiency disease |
| RS2126740125 |
HSD17B4
|
Health Risk |
Pathogenic |
Bifunctional peroxisomal enzyme deficiency, Perrault syndrome |
| RS2126740316 |
HSD17B4
|
Health Risk |
Pathogenic/Likely pathogenic |
Bifunctional peroxisomal enzyme deficiency, Perrault syndrome |
| RS2126745441 |
DNAH5
|
Health Risk |
Pathogenic |
Primary ciliary dyskinesia, Primary ciliary dyskinesia |
| RS2126745614 |
MTRR
|
Health Risk |
Pathogenic |
Methylcobalamin deficiency type cblE, Methylcobalamin deficiency type cblE |
| RS2126745648 |
MTRR
|
Health Risk |
Pathogenic |
Methylcobalamin deficiency type cblE, Methylcobalamin deficiency type cblE |
| RS2126748513 |
PURA
|
Health Risk |
Likely pathogenic |
— |
| RS2126748515 |
PURA
|
Health Risk |
Likely pathogenic |
PURA-related severe neonatal hypotonia-seizures-encephalopathy syndrome, PURA-related severe neonatal hypotonia-seizures-encephalopathy syndrome |
| RS2126748581 |
PURA
|
Health Risk |
Pathogenic |
PURA-related severe neonatal hypotonia-seizures-encephalopathy syndrome, PURA-related severe neonatal hypotonia-seizures-encephalopathy syndrome |
| RS2126748783 |
PURA
|
Health Risk |
Pathogenic |
PURA-related severe neonatal hypotonia-seizures-encephalopathy syndrome, PURA-related severe neonatal hypotonia-seizures-encephalopathy syndrome |
| RS2126748787 |
PURA
|
Health Risk |
Pathogenic |
— |
| RS2126748816 |
PURA
|
Health Risk |
Likely pathogenic |
— |
| RS2126748823 |
PURA
|
Health Risk |
Likely pathogenic |
— |
| RS2126748830 |
PURA
|
Health Risk |
Likely pathogenic |
PURA-related severe neonatal hypotonia-seizures-encephalopathy syndrome, PURA-related severe neonatal hypotonia-seizures-encephalopathy syndrome |
| RS2126748837 |
PURA
|
Health Risk |
Likely pathogenic |
See cases, See cases |
| RS2126748843 |
PURA
|
Health Risk |
Pathogenic |
PURA-related severe neonatal hypotonia-seizures-encephalopathy syndrome, PURA-related severe neonatal hypotonia-seizures-encephalopathy syndrome |
| RS2126748922 |
PURA
|
Health Risk |
Pathogenic |
PURA-related severe neonatal hypotonia-seizures-encephalopathy syndrome, PURA-related severe neonatal hypotonia-seizures-encephalopathy syndrome |
| RS2126748969 |
PURA
|
Health Risk |
Pathogenic |
PURA-related severe neonatal hypotonia-seizures-encephalopathy syndrome due to a point mutation, PURA-related severe neonatal hypotonia-seizures-encephalopathy syndrome due to a point mutation |
| RS2126748986 |
PURA
|
Health Risk |
Likely pathogenic |
PURA-related severe neonatal hypotonia-seizures-encephalopathy syndrome, PURA-related severe neonatal hypotonia-seizures-encephalopathy syndrome |
| RS2126749006 |
PURA
|
Health Risk |
Pathogenic |
PURA-related severe neonatal hypotonia-seizures-encephalopathy syndrome, PURA-related severe neonatal hypotonia-seizures-encephalopathy syndrome |
| RS2126749009 |
PURA
|
Health Risk |
Pathogenic |
PURA-related severe neonatal hypotonia-seizures-encephalopathy syndrome, PURA-related severe neonatal hypotonia-seizures-encephalopathy syndrome |
| RS2126749031 |
PURA
|
Health Risk |
Pathogenic |
PURA-related severe neonatal hypotonia-seizures-encephalopathy syndrome, PURA-related severe neonatal hypotonia-seizures-encephalopathy syndrome |
| RS2126749067 |
PURA
|
Health Risk |
Pathogenic |
PURA-related severe neonatal hypotonia-seizures-encephalopathy syndrome, PURA-related severe neonatal hypotonia-seizures-encephalopathy syndrome |
| RS2126749113 |
PURA
|
Health Risk |
Conflicting classifications of pathogenicity |
PURA-related severe neonatal hypotonia-seizures-encephalopathy syndrome, PURA-related severe neonatal hypotonia-seizures-encephalopathy syndrome |
| RS2126749118 |
PURA
|
Health Risk |
Pathogenic |
PURA-related severe neonatal hypotonia-seizures-encephalopathy syndrome, PURA-related severe neonatal hypotonia-seizures-encephalopathy syndrome |
| RS2126749156 |
PURA
|
Health Risk |
Pathogenic |
PURA-related severe neonatal hypotonia-seizures-encephalopathy syndrome, PURA-related severe neonatal hypotonia-seizures-encephalopathy syndrome |
| RS2126749179 |
PURA
|
Health Risk |
Pathogenic |
PURA-related severe neonatal hypotonia-seizures-encephalopathy syndrome, PURA-related severe neonatal hypotonia-seizures-encephalopathy syndrome |
| RS2126749210 |
PURA
|
Health Risk |
Pathogenic |
PURA-related severe neonatal hypotonia-seizures-encephalopathy syndrome, PURA-related severe neonatal hypotonia-seizures-encephalopathy syndrome due to a point mutation |
| RS2126749241 |
PURA
|
Health Risk |
Likely pathogenic |
PURA-related severe neonatal hypotonia-seizures-encephalopathy syndrome, PURA-related severe neonatal hypotonia-seizures-encephalopathy syndrome |
| RS2126749287 |
PURA
|
Health Risk |
Pathogenic |
PURA-related severe neonatal hypotonia-seizures-encephalopathy syndrome, PURA-related severe neonatal hypotonia-seizures-encephalopathy syndrome |
| RS2126749301 |
PURA
|
Health Risk |
Pathogenic |
PURA-related severe neonatal hypotonia-seizures-encephalopathy syndrome, PURA-related severe neonatal hypotonia-seizures-encephalopathy syndrome |
| RS2126749353 |
PURA
|
Health Risk |
Pathogenic |
PURA-related severe neonatal hypotonia-seizures-encephalopathy syndrome, PURA-related severe neonatal hypotonia-seizures-encephalopathy syndrome |
| RS2126749415 |
PURA
|
Health Risk |
Pathogenic |
— |
| RS2126749442 |
PURA
|
Health Risk |
Likely pathogenic |
PURA-related severe neonatal hypotonia-seizures-encephalopathy syndrome, PURA-related severe neonatal hypotonia-seizures-encephalopathy syndrome |
| RS2126749445 |
PURA
|
Health Risk |
Likely pathogenic |
— |
| RS2126749456 |
PURA
|
Health Risk |
Likely pathogenic |
— |
| RS2126749469 |
PURA
|
Health Risk |
Pathogenic |
PURA-related severe neonatal hypotonia-seizures-encephalopathy syndrome, PURA-related severe neonatal hypotonia-seizures-encephalopathy syndrome |
| RS2126751711 |
HSD17B4
|
Health Risk |
Pathogenic |
Bifunctional peroxisomal enzyme deficiency, Perrault syndrome |